Ventas, Inc. (NYSE: VTR) is a Real Estate company in the REIT - Healthcare Facilities industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
Latest market price
89.38
-0.49-0.55%
News
Down 0.5% — Payrolls Put The Fed Back To Work (SeekingAlpha).
Medium confidence
TA
Loading chart...
Snapshot
| Index | S&P 500 | P/E | 165.52 | EPS (ttm) | 0.54 | Insider Own | 0.55% | Shs Outstand | 486.17M | Perf Week | -2.92% |
| Market Cap | 43.45B | Forward P/E | 94.92 | EPS next Y | 0.94 | Insider Trans | 0.05% | Shs Float | 510.05M | Perf Month | -2.79% |
| Enterprise Value | 56.90B | PEG | 3.36 | EPS next Q | 0.16 | Inst Own | 109.25% | Short Float | 4.65% | Perf Quarter | 8.38% |
| Income | 266.00M | P/S | 6.75 | EPS this Y | 7.93% | Inst Trans | 24.15% | Short Ratio | 6.23 | Perf Half Y | 3.83% |
| Sales | 6.44B | P/B | 2.86 | EPS next Y | 61.57% | ROA | 0.90% | Short Interest | 23.70M | Perf YTD | 15.51% |
| Book/sh | 31.29 | P/C | - | EPS next 5Y | 49.31% | ROE | 2.02% | 52W High | 101.60 -12.03% | Perf Year | 31.29% |
| Cash/sh | 0.41 | P/FCF | 27.34 | EPS past 3/5Y | - -14.33% | ROIC | 22.32% | 52W Low | 66.54 34.33% | Perf 3Y | 107.47% |
| Dividend Est. | 2.08 (2.33%) | EV/EBITDA | 22.79 | Sales past 3/5Y | 12.21% 8.98% | Gross Margin | -2.58% | Volatility | 1.95% 1.97% | Perf 5Y | 59.78% |
| Dividend TTM | 2.00 (2.24%) | EV/Sales | 8.83 | EPS Y/Y TTM | 184.21% | Oper. Margin | 12.94% | ATR (14) | 1.96 | Perf 10Y | 21.47% |
| Dividend Ex-Date | Jun 30, 2026 | Quick Ratio | 0.27 | Sales Y/Y TTM | 30.83% | Profit Margin | 4.13% | RSI (14) | 39.46 | Recom | 2.50 |
| Dividend Gr. 3/5Y | 2.17% -2.17% | Current Ratio | 0.27 | EPS Q/Q | -6.67% | SMA20 | -2.49% | Beta | 0.73 | Target Price | 99.43 |
| Payout | 348.97% | Debt/Eq | 1.05 | Sales Q/Q | 21.75% | SMA50 | -3.74% | Rel Volume | 1.03 | Prev Close | 89.87 |
| Employees | 542 | LT Debt/Eq | 1.05 | Earnings | Oct 28 | SMA200 | 4.82% | Avg Volume | 3.58M | Price | 89.38 |
| IPO Date | May 05, 1997 | Option/Short | Yes / Yes | EPS/Sales Surpr. | -1.64% 2.91% | Net Debt/EBITDA | 5.39 | Volume | 3,707,972 | Change | -0.55% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Sep-01-26 | Reiterated | Wells Fargo | Overweight | $88 → $104 |
| Aug-31-26 | Reiterated | Barclays | Equal Weight | $99 → $102 |
| Aug-11-26 | Reiterated | BMO Capital | Outperform | $100 → $107 |
| Jul-31-26 | Reiterated | Cantor Fitzgerald | Overweight | $93 → $102 |
| Jul-22-26 | Reiterated | Mizuho | Outperform | $98 → $104 |
| Jul-07-26 | Downgrade | Barclays | Overweight → Equal Weight | $67 → $99 |
| Jun-18-26 | Reiterated | Scotiabank | Sector Perform | $95 → $88 |
| Jun-16-26 | Resumed | Raymond James | Outperform | $78 → $94 |
| Jun-16-26 | Reiterated | Deutsche Bank | Buy | $95 → $100 |
| May-22-26 | Reiterated | Mizuho Securities | Outperform | $61 → $98 |
Latest News· Times ET
Sep-07-26
Sep-04-26
Sep-02-26
Aug-31-26
Aug-28-26
Aug-27-26
Aug-23-26
12:32AM
Callan Family Office LLC Buys Shares of 25,940 Ventas, Inc. $VTRdefenseworld.net
Aug-21-26
Aug-21-2611:39PM
Aug-17-26
04:30AM
Ventas Releases 2025-2026 Corporate Sustainability Reportbusinesswire.com
Aug-14-26
Aug-10-26
Aug-02-26
Jul-31-26
Company
Ventas, Inc. is an S&P 500 company enabling exceptional environments that benefit a large and growing aging population. With approximately 1,450 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy. The Company’s growth is fueled by its more than 900 senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments. Ventas aims to deliver outsized performance by leveraging its operational expertise, data-driven insights from its Ventas OITM platform, extensive relationships and strong financial position. The Ventas portfolio also includes outpatient medical buildings, research centers and healthcare facilities. Ventas, Inc. is based in Illinois, Chicago. Ventas, Inc. was incorporated in 1983 in Maryland.
Ownership
Total institutional ownership109.25%
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 6,442 | 5,834 | 4,924 | — | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 6,609 | 6,178 | 2,827 | — | — | — | — | — | — | |
| Gross Profit | -167 | -344 | 2,097 | — | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 191 | 177 | 163 | — | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | — | — | — | — | — | — | |
| Other Operating Expense | -1,190 | -1,348 | 1,253 | — | — | — | — | — | — | |
| Operating Income | 834 | 827 | 681 | — | — | — | — | — | — | |
| Interest Expense | 770 | 612 | 603 | — | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 164 | 33 | -28 | — | — | — | — | — | — | |
| Net Income Before Taxes | 227 | 247 | 51 | — | — | — | — | — | — | |
| Income Taxes | -49 | -14 | -38 | — | — | — | — | — | — | |
| Consolidated Net Income | 266 | 251 | 81 | — | — | — | — | — | — | |
| Net Income From Continuing Operations | 277 | 262 | 88 | — | — | — | — | — | — | |
| Net Income | 266 | 251 | 81 | — | — | — | — | — | — | |
| EPS (Recurring) | 0.55 | 0.55 | 0.20 | — | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 0.55 | 0.55 | 0.20 | — | — | — | — | — | — | |
| EPS (Diluted) | 0.54 | 0.54 | 0.19 | — | — | — | — | — | — | |
| EBITDA | 2,497 | 2,239 | 1,937 | — | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 165.52 | 143.30 | 309.95 | — | — | — | — | — | — | |
| Price To Sales Ratio | 6.70 | 6.03 | 4.93 | — | — | — | — | — | — | |
| Gross Margin | -2.59 | -5.90 | 42.59 | — | — | — | — | — | — | |
| Operating Margin | 12.95 | 14.18 | 13.83 | — | — | — | — | — | — | |
| Net Margin | 4.13 | 4.30 | 1.65 | — | — | — | — | — | — | |
| Shares Outstanding | 483 | 455 | 412 | — | — | — | — | — | — | |
| Market Capitalization | 43,171 | 35,208 | 24,263 | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| EMBLER MICHAEL J | Director | Jun 03 '26 | Buy | 78.81 | 2,500 | 197,025 | 19,202 | Jun 05 |
| RAKOWICH WALTER C | Director | May 14 '26 | Sale | 90.20 | 1,152 | 103,915 | 28,349 | May 15 |
| Roberts Carey S. | EVP and GC | Feb 11 '26 | Sale | 85.00 | 35,532 | 3,020,117 | 72,755 | Feb 13 |
| CAFARO DEBRA A | Chairman and CEO | Feb 06 '26 | Option Exercise | 73.71 | 10,322 | 760,835 | 1,124,356 | Feb 10 |
| CAFARO DEBRA A | Chairman and CEO | Feb 06 '26 | Sale | 82.23 | 10,322 | 848,751 | 1,114,034 | Feb 10 |
| CAFARO DEBRA A | Chairman and CEO | Feb 02 '26 | Sale | 77.66 | 10,322 | 801,605 | 1,114,034 | Feb 03 |
| CAFARO DEBRA A | Chairman and CEO | Feb 02 '26 | Option Exercise | 73.71 | 10,322 | 760,835 | 1,124,356 | Feb 03 |
| CAFARO DEBRA A | Chairman and CEO | Jan 02 '26 | Option Exercise | 73.71 | 10,322 | 760,835 | 1,156,017 | Jan 06 |
| CAFARO DEBRA A | Chairman and CEO | Jan 02 '26 | Sale | 77.26 | 10,322 | 797,475 | 1,145,695 | Jan 06 |
| Probst Robert F | EVP and CFO | Jan 02 '26 | Sale | 77.25 | 29,930 | 2,312,188 | 138,434 | Jan 06 |
| CAFARO DEBRA A | Chairman and CEO | Dec 01 '25 | Option Exercise | 73.71 | 10,322 | 760,835 | 1,156,017 | Dec 03 |
| CAFARO DEBRA A | Chairman and CEO | Dec 01 '25 | Sale | 80.55 | 10,322 | 831,419 | 1,145,695 | Dec 03 |
| Bulgarelli Peter J. | EVP OM&R-Ventas/Pres&CEO-LHS | Nov 19 '25 | Sale | 80.08 | 2,229 | 178,504 | 106,488 | Nov 20 |
| Bulgarelli Peter J. | EVP OM&R-Ventas/Pres&CEO-LHS | Nov 18 '25 | Sale | 80.01 | 2,771 | 221,701 | 108,717 | Nov 20 |
| CAFARO DEBRA A | Chairman and CEO | Nov 17 '25 | Option Exercise | 73.71 | 41,294 | 3,043,781 | 1,186,989 | Nov 19 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.